Literature DB >> 2183547

Structure-activity relationship of chemically synthesized nonreducing parts of lipid A analogs.

J Y Homma1, M Matsuura, Y Kumazawa.   

Abstract

Some synthetic compounds of the nonreducing part of lipid A were found to preserve significant immunopharmacological activities of the endotoxin, at the same time showing very slight if any endotoxic activity such as pyrogenicity lethality or Shwartzman reactivity. Thus, divers activities of the endotoxin which had earlier been considered intrinsic and inseparable were shown to be separable when certain synthetic analogs of lipid A-subunit are at work. The combination of acyl components as well as phosphorylation and acylation positions in these partial structure analogs of lipid A affect the expression of biological activities of the endotoxin. Moreover, stereospecificities of acyl substituents contribute differently to enhance the various biological activities of the endotoxin. It was remarkable that protective activities of the endotoxin such as enhancing nonspecific resistance against microbial infections and antitumor activity are preserved in lipid A-subunit analogs of small molecular weight of ca. 1,000, which at the same time lose all or most toxic activity such as pyrogenicity, lethality and Shwartzman reactivity. It is hoped that new derivatives of lipid A and/or lipid A-subunit which exert only limited biological activities of endotoxin, whether they be protective or toxic, can be synthesized in order to clarify the structural requirements for expressing a given activity. Such compounds will be useful not only for promoting basic endotoxin research but also for application in clinical medicine. Further detailed experiments on the structure-activity relationships of the newly synthesized 4-O-phosphono-D-glucosamine derivatives binding acyl substituents of varying carbon chain length at the 2-N- and 3-O- positions are in progress.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2183547     DOI: 10.1007/978-1-4757-5140-6_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

Review 1.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

2.  Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.

Authors:  Umeharu Ohto; Koichi Fukase; Kensuke Miyake; Toshiyuki Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-24       Impact factor: 11.205

3.  Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta.

Authors:  K Kishi; K Hirai; K Hiramatsu; T Yamasaki; M Nasu
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

4.  MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation.

Authors:  Jianmin Meng; Egil Lien; Douglas T Golenbock
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

Review 5.  Reviewing and identifying amino acids of human, murine, canine and equine TLR4 / MD-2 receptor complexes conferring endotoxic innate immunity activation by LPS/lipid A, or antagonistic effects by Eritoran, in contrast to species-dependent modulation by lipid IVa.

Authors:  Thomas Scior; Christian Alexander; Ulrich Zaehringer
Journal:  Comput Struct Biotechnol J       Date:  2013-04-05       Impact factor: 7.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.